Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2026, the Compensation Committee of the ...

In the animal world, power is not always measured in kilograms or muscle mass. A single, well placed venomous bite can topple an animal ten times the attacker’s size, turning tiny predators into ...

Atossa Therapeutics ( ($ATOS) ) has issued an update. On January 6, 2026, Atossa Therapeutics announced that the U.S. Food ...

Strong PALSONIFY U.S. Launch Execution Resulted in Unaudited and Preliminary Net Product Revenue of >$5 Million for Fourth-Quarter 2025, with ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) ('Crinetics”), a pharmaceutical company focused on the discovery, development ...

India's third-largest drugmaker Cipla has made an early impact in the fast-expanding anti-obesity drug market, with its GLP-1 ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on Monday, January 5, 2026 at 8:30 ...

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet ...

With a pattern of chemical industry deception of independent scientific review, and the recent retraction of an influential ...